首页 › 基金 › Cormorant Asset Management, LP › ARTV
Cormorant Asset Management, LP 对 ARTV 的持仓历史
ARTIVA BIOTHERAPEUTICS INC · 医疗保健
Cormorant Asset Management, LP 在 Q3 2026 的 13F 申报中披露持有 ARTV(ARTIVA BIOTHERAPEUTICS INC)1,815,740 股,市值约 US$30.3M,约占其申报组合的 2.17%,在其申报持仓中市值排名第 16 位。 Cormorant Asset Management, LP 最近 9 个申报季度中有 3 个季度披露了 ARTV 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Cormorant Asset Management, LP 对 ARTV 的持仓演变
Cormorant Asset Management, LP 于 Q3 2024 首次披露 ARTV 持仓:103,633 股(约 US$1.6M)。 该持仓在 Q3 2026 达到峰值 1,815,740 股,市值约 US$30.3M。 在 3 次申报中,Cormorant Asset Management, LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 1,815,740 股、市值约 US$30.3M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 103.63K | $1.60M | 新进 |
| Q4 2024 | 103.63K | $1.04M | 持有 |
| Q3 2026 | 1.82M | $30.32M | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ARTV 与 13F 数据
ARTV(ARTIVA BIOTHERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 87 只申报持有 ARTV,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$220.2M), 5AM Venture Management, LLC (US$139.1M), Deep Track Capital, LP (US$73.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ARTV 的基金
- RA CAPITAL MANAGEMENT, L.P. 23.79M 股 · $220.20M · Q3 2026
- 5AM Venture Management, LLC 9.68M 股 · $139.10M · Q3 2026
- Deep Track Capital, LP 4.41M 股 · $73.62M · Q3 2026
- Blue Owl Capital Holdings LP 4.13M 股 · $63.84M · Q3 2026
- Foresite Capital Management V, LLC 3.56M 股 · $59.50M · Q3 2026
- Foresite Capital Management VI LLC 2.20M 股 · $36.80M · Q3 2026
- ORBIMED ADVISORS LLC 1.68M 股 · $27.98M · Q3 2026
- Venrock Adviser, LLC 2.04M 股 · $14.55M · Q3 2026
- Sanofi 672.78K 股 · $11.24M · Q3 2026
- Caligan Partners LP 1.48M 股 · $10.55M · Q3 2026
- Samsara BioCapital, LLC 954.86K 股 · $6.80M · Q3 2026
- Saturn V Capital Management LP 300.36K 股 · $5.02M · Q3 2026
更多关于 Cormorant Asset Management, LP
常见问题
How long has Cormorant Asset Management, LP held ARTV?
Cormorant Asset Management, LP has disclosed ARTV holdings in 3 of the last 9 reported quarters, going back to Q3 2024.
What is Cormorant Asset Management, LP's current position in ARTV?
As of Q3 2026, Cormorant Asset Management, LP holds 1.82M shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $30.32M, representing 2.17% of its reported portfolio and ranking #16.
Has Cormorant Asset Management, LP been buying or selling ARTV?
In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP newly opened its position in ARTV. The position peaked in Q3 2026 at 1.82M shares.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Deep Track Capital, LP, among 87 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.